Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining, Recognising and Escalating Maternal Early Deterioration (DREaMED): Decreasing Inequality Through Improved Outcomes.

NCT06560931 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06560931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06560931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining, Recognising and Escalating Maternal Early Deterioration (DREaMED): Decreasing Inequality Through Improved Outcomes.
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Active, not recruiting
Start date
May 2, 2023
Completion date
May 1, 2029
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy complications, pregnancy, high risk